C. Gr?Valos
AuthID: R-00J-Z9W
1
TÃTULO: Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC)
AUTORES: Argiles, G; Margalef, NM; Valladares Ayerbes, M; de Prado, JV; Grávalos, C; Alfonso, PG; Santos, C; Tobeña, M; Sastre, J; Benavides, M; Cano, T; Loupakis, F; Garrote, MR; Rivera, F; Goldberg, R; Falcone, A; Bennouna, J; Ciardiello, F; Tabernero, J; Aranda, E;
PUBLICAÇÃO: 2019, FONTE: Annals of oncology : official journal of the European Society for Medical Oncology, VOLUME: 30
AUTORES: Argiles, G; Margalef, NM; Valladares Ayerbes, M; de Prado, JV; Grávalos, C; Alfonso, PG; Santos, C; Tobeña, M; Sastre, J; Benavides, M; Cano, T; Loupakis, F; Garrote, MR; Rivera, F; Goldberg, R; Falcone, A; Bennouna, J; Ciardiello, F; Tabernero, J; Aranda, E;
PUBLICAÇÃO: 2019, FONTE: Annals of oncology : official journal of the European Society for Medical Oncology, VOLUME: 30
INDEXADO EM: 
Scopus
Scopus